Infections with two pathogens pose a serious threat in the clinics. Researchers have developed a technique that provides new insights into this process and can be used as an early warning system.
Diabetes, hypertension may increase risk of COVID-19 brain complications
Some patients with COVID-19 are at higher risk of neurological complications like bleeding in the brain and stroke, according to a new study. The researchers said these potentially life-threatening findings were more common in patients with hypertensio…
Kids mount a COVID-19 immune response without detection of the SARSCoV-2 virus, case study finds
Children in an Australian family developed a COVID-19 immune response after chronic exposure to the SARS-CoV-2 virus from their parents, a new case report has found.
Study reveals how smoking worsens COVID-19 infection in the airways
Researchers using a model of airway tissue created from human stem cells have pinpointed how smoking cigarettes causes more severe infection by SARS-CoV-2, the virus that causes COVID-19, in the airways of the lungs.
Chronic alcohol use reshapes the brain’s immune landscape, driving anxiety and addiction
Deep within the brain, a small almond-shaped region called the amygdala plays a vital role in how we exhibit emotion, behavior and motivation; it’s also strongly implicated in alcohol abuse. Now, for the first time, a team has identified important chan…
Parasite infection discovery could assist mental health treatments
New research into how a common parasite infection alters human behavior could help development of treatments for schizophrenia and other neurological disorders. T. gondii currently infects 2.5 billion people worldwide and causes the disease Toxoplasmos…
Parasitic worms offer ‘the missing link’ on the dual nature of a key immune regulator
By studying two models of parasite infection, researchers filled in crucial gaps about the activity of the signaling molecule IL-33 that is critical to asthma, allergies, and other diseases.
Antibody evolution may predict COVID-19 outcomes
A new study shows differences in early antibody evolution between patients who survived severe COVID-19 and those who died from it.
Promising MS drug may worsen disease
The drug has not yet made it to human trials for multiple sclerosis, but scientists are urging their colleagues to move cautiously.
Dissecting the immune characteristics of severe COVID-19 responses
New research adds to the developing picture of the immune system response and our understanding of the immunological features associated with the development of severe and life-threatening disease following COVID-19.